Analyze Diet

Dermatitis, cellulitis, and osteomyelitis caused by Aspergillus nidulans in a horse with pituitary pars intermedia dysfunction.

Abstract: Clinical and histologic examination of a 12-y-old client-owned Quarter Horse gelding with pituitary pars intermedia dysfunction revealed dermatitis, cellulitis, and osteomyelitis caused by , confirmed by a PCR assay. This novel presentation of a fungal disease in a horse was characterized by aggressive local invasion and failure to respond to all medical therapy attempted over a 1-y period. Treatments included systemic and topical antifungals, anti-inflammatories, and use of cellular matrices. Surgical excision was not attempted but should be strongly considered early in the disease process in similar cases if clean margins can be achieved. Postmortem findings were of locally aggressive disease with no dissemination.
Publication Date: 2024-03-11 PubMed ID: 38462742PubMed Central: PMC10929629DOI: 10.1177/10406387241226942Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Case Reports
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The article investigates a rare presentation of a fungal disease caused by Aspergillus nidulans in a 12-year-old Quarter Horse with pituitary pars intermedia dysfunction, manifesting as dermatitis, cellulitis, and osteomyelitis. Despite aggressive therapeutic interventions over a year, the disease progression could not be halted and surgical excision at an early stage is suggested for similar cases in future.

Patient Background and Clinical Examination

  • The study is centered around a case of a 12-year-old Quarter Horse gelding (a male horse that is castrated) with an existing condition of pituitary pars intermedia dysfunction.
  • Detailed clinical and histologic examinations were conducted which revealed dermatitis (skin inflammation), cellulitis (a bacterial skin infection), and osteomyelitis (bone infection) in the horse.

Identification of Fungal Disease

  • The cause of these conditions was found to be Aspergillus nidulans, a species of fungus, confirmed through Polymerase Chain Reaction (PCR) assay, a molecular biology technique.
  • This fungal disease present in the horse is characterized by aggressive local invasion, and has not previously been reported in equine patients. As such, it represents a novel presentation of equine fungal disease.

Treatment and Outcomes

  • The researchers detail various treatment methods that were attempted over a one-year span to curb the disease progression. These included systemic and topical antifungals to combat the fungus, anti-inflammatories to reduce inflammation, and the utilization of cellular matrices—a treatment where cellular structures are applied to aid healing.
  • Despite these, the fungal disease did not respond to any medical therapy, showing its resistant nature.

Surgical Recommendations and Postmortem Findings

  • While surgical excision (removal of the disease tissues) was not attempted in this case, the study suggests that such an approach should be strongly considered early in the disease process for similar cases in the future, provided clean margins (complete removal of disease tissue) can be achieved.
  • Postmortem examination of the horse revealed that the disease was locally aggressive but had not disseminated (spread) to other parts of the body.

Cite This Article

APA
Waitt Wolker LH, Black A, Lee JK. (2024). Dermatitis, cellulitis, and osteomyelitis caused by Aspergillus nidulans in a horse with pituitary pars intermedia dysfunction. J Vet Diagn Invest, 36(2), 248-253. https://doi.org/10.1177/10406387241226942

Publication

ISSN: 1943-4936
NlmUniqueID: 9011490
Country: United States
Language: English
Volume: 36
Issue: 2
Pages: 248-253

Researcher Affiliations

Waitt Wolker, Laura H
  • Departments of Equine Medicine and Surgery, College of Veterinary Medicine Animal Health Institute, Midwestern University, Glendale, AZ, USA.
Black, Annalise
  • Pathology, College of Veterinary Medicine Animal Health Institute, Midwestern University, Glendale, AZ, USA.
Lee, Jung Keun
  • Pathology, College of Veterinary Medicine Animal Health Institute, Midwestern University, Glendale, AZ, USA.

MeSH Terms

  • Horses
  • Male
  • Animals
  • Aspergillus nidulans
  • Cellulitis / veterinary
  • Horse Diseases / diagnosis
  • Horse Diseases / pathology
  • Pituitary Diseases / diagnosis
  • Pituitary Diseases / veterinary
  • Pituitary Gland, Intermediate / pathology
  • Osteomyelitis / diagnosis
  • Osteomyelitis / veterinary
  • Dermatitis / pathology
  • Dermatitis / veterinary

Conflict of Interest Statement

Declaration of conflicting interestsThe authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

References

This article includes 21 references
  1. Blomme E. Aspergillosis in horses: a review.. Equine Vet Educ 1998;10:86–93.
  2. Cafarchia C. Fungal diseases of horses.. Vet Microbiol 2013;167:215–234.
    pubmed: 23428378
  3. Carrasco L. Chronic bronchopulmonary aspergillosis in a horse with Cushing’s syndrome.. Mycoses 1996;39:443–447.
    pubmed: 9145001
  4. Elad D, Segal E. Diagnostic aspects of veterinary and human aspergillosis.. Front Microbiol 2018;9:1303.
    pmc: PMC6022203pubmed: 29977229
  5. Freeman DE. Update on disorders and treatment of the guttural pouch.. Vet Clin North Am Equine Pract 2015;31:63–89.
    pubmed: 25770066
  6. Hanson RR. Complications of equine wound management and dermatologic surgery.. Vet Clin North Am Equine Pract 2008;24:663–696.
    pubmed: 19203707
  7. Henneke DR. Relationship between condition score, physical measurements and body fat percentage in mares.. Equine Vet J 1983;15:371–372.
    pubmed: 6641685
  8. Itoi S. In vitro activities of antifungal agents against clinical isolates of dermatophytes from animals.. J Vet Med Sci 2012;74:1067–1069.
    pubmed: 22467073
  9. Keegan KG. Subcutaneous mycetoma-like granuloma in a horse caused by Aspergillus versicolor.. J Vet Diagn Invest 1995;7:564–567.
    pubmed: 8580188
  10. Kidd SE. Antifungal susceptibility testing and identification.. Infect Dis Clin North Am 2021;35:313–339.
    pubmed: 34016280
  11. Kirkwood NC. Pituitary pars intermedia dysfunction (PPID) in horses.. Vet Sci 2022;9:556.
    pmc: PMC9611634pubmed: 36288169
  12. Lee SK. Fungal dermatitis caused by Aspergillus sydowii in a Thoroughbred horse.. J Equine Vet Sci 2012;32:835–839.
  13. Ludwig A. Fungal isolation and identification in 21 cases of guttural pouch mycosis in horses (1998–2002).. Vet J 2005;169:457–461.
    pubmed: 15848789
  14. Macías-Rioseco M. Coccidioidomycosis in 26 horses in California, USA: case series and review of the literature.. J Vet Diagn Invest 2022;34:995–999.
    pmc: PMC9597331pubmed: 35879871
  15. Seyedmousavi S. Emerging Aspergillus species almost exclusively associated with primary immunodeficiencies.. Open Forum Infect Dis 2018;5:ofy213.
    pmc: PMC6157306pubmed: 30568990
  16. Sherman KM. Fungal osteomyelitis of the axial border of the proximal sesamoid bones in a horse.. J Am Vet Med Assoc 2006;229:1607–1611.
    pubmed: 17107317
  17. Stewart AJ. Update on equine therapeutics: antifungal therapy for horses.. Compend Contin Educ Vet 2005;27:871–876.
  18. Stewart AJ, Cuming RS. Update on fungal respiratory disease in horses.. Vet Clin North Am Equine Pract 2015;31:43–62.
    pubmed: 25620382
  19. Sweeney CR, Habecker PL. Pulmonary aspergillosis in horses: 29 cases (1974–1997).. J Am Vet Med Assoc 1999;214:808–811.
    pubmed: 10101412
  20. Watanabe R. Antifungal susceptibility of dermatophytes from racehorses in Japan.. Vet Dermatol 2021;32:474-e129.
    pubmed: 34189781
  21. Watkins AR, Parente EJ. Salpingopharyngeal fistula as a treatment for guttural pouch mycosis in seven horses.. Equine Vet J 2018;50:781–786.
    pubmed: 29514400

Citations

This article has been cited 0 times.